Literature DB >> 25740155

Functional and molecular evidence for expression of the renin angiotensin system and ADAM17-mediated ACE2 shedding in COS7 cells.

Nadja Grobe1, Mauricio Di Fulvio1, Nada Kashkari1, Harshita Chodavarapu1, Hari K Somineni1, Richa Singh1, Khalid M Elased2.   

Abstract

The renin angiotensin system (RAS) plays a vital role in the regulation of the cardiovascular and renal functions. COS7 is a robust and easily transfectable cell line derived from the kidney of the African green monkey, Cercopithecus aethiops. The aims of this study were to 1) demonstrate the presence of an endogenous and functional RAS in COS7, and 2) investigate the role of a disintegrin and metalloproteinase-17 (ADAM17) in the ectodomain shedding of angiotensin converting enzyme-2 (ACE2). Reverse transcription coupled to gene-specific polymerase chain reaction demonstrated expression of ACE, ACE2, angiotensin II type 1 receptor (AT1R), and renin at the transcript levels in total RNA cell extracts. Western blot and immunohistochemistry identified ACE (60 kDa), ACE2 (75 kDa), AT1R (43 kDa), renin (41 kDa), and ADAM17 (130 kDa) in COS7. At the functional level, a sensitive and selective mass spectrometric approach detected endogenous renin, ACE, and ACE2 activities. ANG-(1-7) formation (m/z 899) from the natural substrate ANG II (m/z 1,046) was detected in lysates and media. COS7 cells stably expressing shRNA constructs directed against endogenous ADAM17 showed reduced ACE2 shedding into the media. This is the first study demonstrating endogenous expression of the RAS and ADAM17 in the widely used COS7 cell line and its utility to study ectodomain shedding of ACE2 mediated by ADAM17 in vitro. The transfectable nature of this cell line makes it an attractive cell model for studying the molecular, functional, and pharmacological properties of the renal RAS.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  ACE2 shedding; ADAM17; COS7; renin angiotensin system

Mesh:

Substances:

Year:  2015        PMID: 25740155      PMCID: PMC4420792          DOI: 10.1152/ajpcell.00247.2014

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  58 in total

1.  G protein coupling and second messenger generation are indispensable for metalloprotease-dependent, heparin-binding epidermal growth factor shedding through angiotensin II type-1 receptor.

Authors:  Mizuo Mifune; Haruhiko Ohtsu; Hiroyuki Suzuki; Hidekatsu Nakashima; Eugen Brailoiu; Nae J Dun; Gerald D Frank; Tadashi Inagami; Shigeki Higashiyama; Walter G Thomas; Andrea D Eckhart; Peter J Dempsey; Satoru Eguchi
Journal:  J Biol Chem       Date:  2005-05-19       Impact factor: 5.157

2.  Characterization of a novel type of endogenous activator of soluble guanylyl cyclase.

Authors:  Nataliya Balashova; Fu-Jung Chang; Maria Lamothe; Qian Sun; Annie Beuve
Journal:  J Biol Chem       Date:  2004-10-27       Impact factor: 5.157

3.  Short-hairpin RNA-mediated stable silencing of Grb2 impairs cell growth and DNA synthesis.

Authors:  Mauricio Di Fulvio; Karen M Henkels; Julian Gomez-Cambronero
Journal:  Biochem Biophys Res Commun       Date:  2007-04-10       Impact factor: 3.575

4.  Chronic angiotensin II receptor blockade reduces (intra)renal vascular resistance in patients with type 2 diabetes.

Authors:  Danilo Fliser; Kathrin-Kristin Wagner; Astrid Loos; Dimitrios Tsikas; Hermann Haller
Journal:  J Am Soc Nephrol       Date:  2005-02-16       Impact factor: 10.121

5.  Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.

Authors:  Minghao Ye; Jan Wysocki; Josette William; Maria José Soler; Ivan Cokic; Daniel Batlle
Journal:  J Am Soc Nephrol       Date:  2006-10-04       Impact factor: 10.121

6.  Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells.

Authors:  Fiona J Warner; Rebecca A Lew; A Ian Smith; Daniel W Lambert; Nigel M Hooper; Anthony J Turner
Journal:  J Biol Chem       Date:  2005-09-15       Impact factor: 5.157

7.  New mass spectrometric assay for angiotensin-converting enzyme 2 activity.

Authors:  Khalid M Elased; Tatiana S Cunha; Susan B Gurley; Thomas M Coffman; Mariana Morris
Journal:  Hypertension       Date:  2006-04-03       Impact factor: 10.190

8.  Selective and specific regulation of ectodomain shedding of angiotensin-converting enzyme 2 by tumor necrosis factor alpha-converting enzyme.

Authors:  Michikado Iwata; Jorge E Silva Enciso; Barry H Greenberg
Journal:  Am J Physiol Cell Physiol       Date:  2009-09-16       Impact factor: 4.249

9.  Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats.

Authors:  Jorge F Giani; Marcos A Mayer; Marina C Muñoz; Ezequiel A Silberman; Christian Höcht; Carlos A Taira; Mariela M Gironacci; Daniel Turyn; Fernando Pablo Dominici
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-11-11       Impact factor: 4.310

10.  Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2).

Authors:  Daniel W Lambert; Mike Yarski; Fiona J Warner; Paul Thornhill; Edward T Parkin; A Ian Smith; Nigel M Hooper; Anthony J Turner
Journal:  J Biol Chem       Date:  2005-06-27       Impact factor: 5.157

View more
  11 in total

1.  Increased urinary angiotensin converting enzyme 2 and neprilysin in patients with type 2 diabetes.

Authors:  Sridevi Gutta; Nadja Grobe; Meenasri Kumbaji; Hassan Osman; Mohammad Saklayen; Gengxin Li; Khalid M Elased
Journal:  Am J Physiol Renal Physiol       Date:  2018-03-21

2.  Ovulatory upregulation of angiotensin-converting enzyme 2, a receptor for SARS-CoV-2, in dominant follicles of the human ovary.

Authors:  Yohan Choi; Hayce Jeon; Mats Brännström; James W Akin; Thomas E Curry; Misung Jo
Journal:  Fertil Steril       Date:  2021-08-11       Impact factor: 7.490

3.  Local corticosterone production and angiotensin-I converting enzyme shedding in a mouse model of intestinal inflammation.

Authors:  Hanne Salmenkari; Tomi Issakainen; Heikki Vapaatalo; Riitta Korpela
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

4.  MAGI-1 PDZ2 Domain Blockade Averts Adenovirus Infection via Enhanced Proteolysis of the Apical Coxsackievirus and Adenovirus Receptor.

Authors:  Mahmoud S Alghamri; Priyanka Sharma; Timothy L Williamson; James M Readler; Ran Yan; S Dean Rider; Heather A Hostetler; David R Cool; Abimbola O Kolawole; Katherine J D A Excoffon
Journal:  J Virol       Date:  2021-06-10       Impact factor: 5.103

5.  Plasma Membrane Targeting of Endogenous NKCC2 in COS7 Cells Bypasses Functional Golgi Cisternae and Complex N-Glycosylation.

Authors:  Richa Singh; Shams Kursan; Mohamed Y Almiahoub; Mohammed M Almutairi; Tomás Garzón-Muvdi; Francisco J Alvarez-Leefmans; Mauricio Di Fulvio
Journal:  Front Cell Dev Biol       Date:  2017-01-04

Review 6.  Interactions between antihyperglycemic drugs and the renin-angiotensin system: Putative roles in COVID-19. A mini-review.

Authors:  Afif Nakhleh; Naim Shehadeh
Journal:  Diabetes Metab Syndr       Date:  2020-05-05

7.  Protein Kinase C-δ Mediates Shedding of Angiotensin-Converting Enzyme 2 from Proximal Tubular Cells.

Authors:  Fengxia Xiao; Joseph Zimpelmann; Dylan Burger; Christopher Kennedy; Richard L Hébert; Kevin D Burns
Journal:  Front Pharmacol       Date:  2016-06-01       Impact factor: 5.810

Review 8.  ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives.

Authors:  Federica Saponaro; Grazia Rutigliano; Simona Sestito; Lavinia Bandini; Barbara Storti; Ranieri Bizzarri; Riccardo Zucchi
Journal:  Front Mol Biosci       Date:  2020-09-30

9.  Oxygen conditions oscillating between hypoxia and hyperoxia induce different effects in the pulmonary endothelium compared to constant oxygen conditions.

Authors:  Peter Wohlrab; Michael Johann Danhofer; Wolfgang Schaubmayr; Akos Tiboldi; Katharina Krenn; Klaus Markstaller; Roman Ullrich; Klaus Ulrich Klein; Verena Tretter
Journal:  Physiol Rep       Date:  2021-02

10.  The Priming Potential of Interferon Lambda-1 for Antiviral Defense in the Oral Mucosa.

Authors:  Yosuke Shikama; Mie Kurosawa; Masae Furukawa; Yasusei Kudo; Naozumi Ishimaru; Kenji Matsushita
Journal:  Inflammation       Date:  2022-01-19       Impact factor: 4.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.